NASDAQ:HOLX

Hologic - HOLX Stock Forecast, Price & News

$64.52

-0.48 (-0.74%)

(As of 09/30/2022 12:00 AM ET)

Add

Compare

Today's Range: $64.30
▼
$66.39
50-Day Range: $62.71
▼
$73.47
52-Week Range: $61.57
▼
$80.49

Volume: 2.06 million shs
Average Volume: 1.53 million shs
Market Capitalization: $16.11 billion

P/E Ratio: 10.88
Dividend Yield: N/A
Price Target: $76.71

Hologic MarketRank™ Forecast

Analyst Rating: Hold
2.30 Rating Score
Upside/Downside: 18.9% Upside
$76.71 Price Target
Short Interest: Healthy
3.07% of Float Sold Short
Dividend Strength: N/A
Sustainability: -0.94
Upright™ Environmental Score
News Sentiment: 0.43
Based on 6 Articles This Week
Insider Trading: N/A
Proj. Earnings Growth: -40.03%
From $5.82 to $3.49 Per Share

Overall MarketRank^™

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.17 out of 5 stars

Medical Sector

467th out of 1,093 stocks

X - Ray Apparatus & Tubes Industry

2nd out of 4 stocks

2.2

Analyst's Opinion

Consensus Rating
Hologic has received a consensus rating of Hold. The company's average rating score is 2.30, and is based on 3 buy ratings, 7 hold ratings, and no sell ratings.
Price Target Upside/Downside
According to analysts' consensus price target of $76.71, Hologic has a forecasted upside of 18.9% from its current price of $64.52.
Amount of Analyst Coverage
Hologic has only been the subject of 4 research reports in the past 90 days.

3.0

Short Interest

Percentage of Shares Shorted
3.07% of the float of Hologic has been sold short.
Short Interest Ratio / Days to Cover
Hologic has a short interest ratio ("days to cover") of 5.
Change versus previous month
Short interest in Hologic has recently decreased by 3.32%, indicating that investor sentiment is improving.

0.0

Dividend Strength

Dividend Yield
Hologic does not currently pay a dividend.
Dividend Growth
Hologic does not have a long track record of dividend growth.

4.2

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score
Hologic has received a 61.62% net impact score from Upright. The largest positive contribution comes from its "Physical diseases" impact, which is mostly driven by its "Ultrasound machines", "Medical x-ray machines", and "Medical image enhancement software" products. See details.
Environmental Sustainability
The Environmental Impact score for Hologic is -0.94.

1.3

News and Social Media Coverage

News Sentiment
Hologic has a news sentiment score of 0.43. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.81 average news sentiment score of Medical companies.
News Coverage This Week
MarketBeat has tracked 6 news articles for Hologic this week, compared to 6 articles on an average week.
Search Interest
Only 3 people have searched for HOLX on MarketBeat in the last 30 days. This is a decrease of -75% compared to the previous 30 days.
MarketBeat Follows
Only 2 people have added Hologic to their MarketBeat watchlist in the last 30 days. This is a decrease of -33% compared to the previous 30 days.

1.7

Company Ownership

Insider Buying vs. Insider Selling
In the past three months, Hologic insiders have not sold or bought any company stock.
Percentage Held by Insiders
Only 1.54% of the stock of Hologic is held by insiders.
Percentage Held by Institutions
85.70% of the stock of Hologic is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

2.5

Earnings and Valuation

Earnings Growth
Earnings for Hologic are expected to decrease by -40.03% in the coming year, from $5.82 to $3.49 per share.
Price to Earnings Ratio vs. the Market
The P/E ratio of Hologic is 10.88, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 118.10.
Price to Earnings Ratio vs. Sector
The P/E ratio of Hologic is 10.88, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 91.46.
Price to Earnings Growth Ratio
Hologic has a PEG Ratio of 0.74. PEG Ratios below 1 indicate that a company could be undervalued.
Price to Book Value per Share Ratio
Hologic has a P/B Ratio of 3.88. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

See Top Rated MarketRank™ Stocks Here

About Hologic (NASDAQ:HOLX) Stock

Hologic, Inc. develops, manufactures, and supplies diagnostics products, medical imaging systems, and surgical products for women's health through early detection and treatment in the United States, Europe, the Asia-Pacific, and internationally. It operates through four segments: Diagnostics, Breast Health, GYN Surgical, and Skeletal Health. The company provides Aptima molecular diagnostic assays to detect the infectious microorganisms; Aptima viral load tests for HIV, Hepatitis C, and Hepatitis B; Aptima SARS-CoV-2 and Panther Fusion SARS-CoV-2 assays for the detection of SARS-CoV-2; ThinPrep System for use in cytology applications; Rapid Fetal Fibronectin Test that assists physicians in assessing the risk of pre-term birth; and various diagnostic tests for the detection of Group B Streptococcus. It also offers breast imaging and analytics, such as 2D and 3D digital mammography systems and reading workstations, minimally invasive breast biopsy guidance systems and devices, breast biopsy site markers and localization, specimen radiology, and ultrasound and connectivity solutions; and breast conserving surgery products. In addition, the company provides NovaSure Endometrial Ablation System for the treatment of abnormal uterine bleeding; MyoSure Hysteroscopic Tissue Removal System for the removal of fibroids, polyps, and other pathology within the uterus; and Fluent Fluid Management System that provides liquid distention during diagnostic and operative hysteroscopic procedures. Further, it offers Horizon DXA, a dual energy X-ray system; and the Fluoroscan Insight FD mini C-arm to perform minimally invasive orthopedic surgical procedures. The company sells its products through direct sales and service forces, and independent distributors and sales representatives. Hologic, Inc. was incorporated in 1985 and is headquartered in Marlborough, Massachusetts.

Receive HOLX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Hologic and its competitors with MarketBeat's FREE daily newsletter.

HOLX Stock News Headlines

September 30, 2022 | nasdaq.com

Hologic (HOLX) Stock Moves -0.35%: What You Should Know - Nasdaq

September 29, 2022 | finance.yahoo.com

Hologic (HOLX) Stock Moves -0.35%: What You Should Know

September 27, 2022 | globenewswire.com

Outlook on the Next-Generation Ultrasound Systems Global Market to 2031 - Featuring Butterfly Network, Canon, Hitachi and Hologic Among Others - GlobeNewswire

September 24, 2022 | americanbankingnews.com

Hologic, Inc. (NASDAQ:HOLX) Receives Average Recommendation of "Hold" from Brokerages

September 23, 2022 | finance.yahoo.com

Molecular Diagnostics Global Market Report 2022 - Yahoo Finance

September 22, 2022 | finance.yahoo.com

Bone Densitometer Global Market Report 2022 - Yahoo Finance

September 22, 2022 | finance.yahoo.com

Hologic (HOLX) Stock Moves -0.29%: What You Should Know

September 20, 2022 | nasdaq.com

September 12, 2022 | nasdaq.com

We Think Hologic (NASDAQ:HOLX) Can Stay On Top Of Its Debt - Nasdaq

September 9, 2022 | finance.yahoo.com

Is Most-Watched Stock Hologic, Inc. (HOLX) Worth Betting on Now? - Yahoo Finance

September 6, 2022 | globenewswire.com

Global Endometrial Ablation Devices Market – Analysis By Device Type, End-User By Region, By Country (2022 Edition): Market Insights and Forecast with Impact of COVID-19 (2023-2028) - GlobeNewswire

September 6, 2022 | globenewswire.com

Medical Aesthetics Market by 2022 to 2029 – ALLERGAN, Solta Medical, and Others - GlobeNewswire

September 3, 2022 | benzinga.com

Boston Scientific Corp. (BSX), Hologic (HOLX) – Interventional Radiology Market Size 2022-2027, Share, In - Benzinga

September 2, 2022 | seekingalpha.com

Hologic Stock: Underappreciated Gem; Bright Future (NASDAQ:HOLX) - Seeking Alpha

August 31, 2022 | benzinga.com

Global Tattoo Removal Market (2022 to 2027) - Featuring Hologic, Light Age, Lutronic and Modern Aestheti - Benzinga

August 30, 2022 | finance.yahoo.com

Global Breast Lesion Localization Methods Market to Grow at a CAGR of ~10% during 2022-2031; Market to Expand Owing to the Growing Cases of Breast Cancer, and Rising Consumption of Contraceptive Pills – Kenneth Research - Yahoo Finance

August 29, 2022 | seekingalpha.com

Hologic Continues To Offer Compelling Long-Term Value, Thesis Unchanged (NASDAQ:HOLX) - Seeking Alpha

August 16, 2022 | finance.yahoo.com

Hologic (HOLX) Just Reclaimed the 200-Day Moving Average - Yahoo Finance

August 16, 2022 | nasdaq.com

Here's How Much a $1000 Investment in Hologic Made 10 Years Ago Would Be Worth Today - Nasdaq

August 16, 2022 | finance.yahoo.com

Hologic (HOLX) Just Reclaimed the 200-Day Moving Average

August 14, 2022 | finance.yahoo.com

How Much Of Hologic, Inc. (NASDAQ:HOLX) Do Institutions Own?

August 12, 2022 | businesswire.com

Hologic and Mary J. Blige Launch “Good Morning Gorgeous” Sweepstakes as a Wake-up Call to Increase Awareness of the Importance of Preventive Care - Business Wire

August 8, 2022 | foxnews.com

Russian tennis players win three of four tournaments ahead of US Open - Fox News

July 31, 2022 | finance.yahoo.com

Active Motif Incorporated Licenses Targeted Transposition to Diagenode S.A. Technology

July 30, 2022 | benzinga.com

Hologic's Return On Capital Employed Overview - Benzinga

See More Headlines

30 days | 90 days | 365 days | Advanced Chart

Receive HOLX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Hologic and its competitors with MarketBeat's FREE daily newsletter.

HOLX Company Calendar

Last Earnings: 7/27/2022
Today: 10/01/2022
Next Earnings (Estimated): 11/07/2022
Fiscal Year End: 9/30/2023

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: X - ray apparatus & tubes
Sub-Industry: Health Care Equipment
Sector: Medical
Current Symbol: NASDAQ:HOLX
CUSIP: 43644010
CIK: 859737
Web: www.hologic.com
Phone: (508) 263-2900
Fax: 781-890-8031
Employees: 6,705
Year Founded: 1985

Price Target and Rating

Average Stock Price Forecast: $76.71
High Stock Price Forecast: $85.00
Low Stock Price Forecast: $70.00
Forecasted Upside/Downside: +18.9%
Consensus Rating: Hold
Rating Score (0-4): 2.30
Research Coverage: 10 Analysts

Profitability

EPS (Most Recent Fiscal Year): $5.93
Trailing P/E Ratio: 10.88
Forward P/E Ratio: 11.09
P/E Growth: 0.74
Net Income: $1.87 billion
Net Margins: 28.93%
Pretax Margin: 35.50%
Return on Equity: 37.48%
Return on Assets: 18.73%

Debt

Debt-to-Equity Ratio: 0.57
Current Ratio: 3.91
Quick Ratio: 3.32

Sales & Book Value

Annual Sales: $5.63 billion
Price / Sales: 2.86
Cash Flow: $10.14 per share
Price / Cash Flow: 6.36
Book Value: $16.64 per share
Price / Book: 3.88

Miscellaneous

Outstanding Shares: 249,650,000
Free Float: 245,808,000
Market Cap: $16.11 billion
Optionable: Optionable
Beta: 1.05

Social Links

Key Executives

Mr. Stephen P. MacMillan (Age 58)
Chairman, CEO & Pres
Comp: $4.51M

Ms. Karleen M. Oberton (Age 51)
Chief Financial Officer
Comp: $1.6M

Mr. John M. Griffin (Age 61)
Gen. Counsel
Comp: $1.56M

Mr. Kevin R. Thornal (Age 48)
Group Pres of Global Diagnostic Solutions
Comp: $1.66M

Mr. Paul Malenchini
Chief Information Officer

Ryan M. Simon
VP of Investor Relations

Ms. Elisabeth A. Hellmann (Age 53)
Sr. VP of Global HR & Corp. Communications

Mr. Jan Verstreken (Age 54)
Group Pres of International

Ms. Monica Aguirre Berthelot
VP & Chief of Staff

Mr. Mike Kelly
Chief Supply Chain Officer and Corp. VP of Quality Assurance & Regulatory Affairs

Key Competitors

View All Competitors

Insiders & Institutions

View All Insider Transactions
View All Institutional Transactions

HOLX Stock - Frequently Asked Questions

Should I buy or sell Hologic stock right now?: 10 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Hologic in the last twelve months. There are currently 7 hold ratings and 3 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "hold" HOLX shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in HOLX, but not buy additional shares or sell existing shares.
View HOLX analyst ratings or view top-rated stocks.
What is Hologic's stock price forecast for 2022?: 10 Wall Street analysts have issued 12 month price targets for Hologic's stock. Their HOLX share price forecasts range from $70.00 to $85.00. On average, they anticipate the company's stock price to reach $76.71 in the next twelve months. This suggests a possible upside of 18.9% from the stock's current price.
View analysts price targets for HOLX or view top-rated stocks among Wall Street analysts.
How have HOLX shares performed in 2022?: Hologic's stock was trading at $76.56 at the beginning of the year. Since then, HOLX shares have decreased by 15.7% and is now trading at $64.52.
View the best growth stocks for 2022 here.
When is Hologic's next earnings date?: The company is scheduled to release its next quarterly earnings announcement on Monday, November 7th 2022.
View our HOLX earnings forecast.
How were Hologic's earnings last quarter?: Hologic, Inc. (NASDAQ:HOLX) released its quarterly earnings data on Wednesday, July, 27th. The medical equipment provider reported $0.95 earnings per share for the quarter, topping the consensus estimate of $0.69 by $0.26. The medical equipment provider had revenue of $1 billion for the quarter, compared to analysts' expectations of $896.71 million. Hologic had a net margin of 28.93% and a trailing twelve-month return on equity of 37.48%. The firm's revenue for the quarter was down 14.2% compared to the same quarter last year. During the same quarter in the previous year, the business earned $1.33 earnings per share.
Read the conference call transcript.
What guidance has Hologic issued on next quarter's earnings?: Hologic updated its fourth quarter 2022 earnings guidance on Thursday, August, 4th. The company provided earnings per share (EPS) guidance of $0.60-$0.65 for the period, compared to the consensus EPS estimate of $0.61. The company issued revenue guidance of $840.00 million-$870.00 million, compared to the consensus revenue estimate of $869.95 million.

What is Steve MacMillan's approval rating as Hologic's CEO?: 447 employees have rated Hologic Chief Executive Officer Steve MacMillan on Glassdoor.com. Steve MacMillan has an approval rating of 79% among the company's employees. 81.0% of employees surveyed would recommend working at Hologic to a friend.
What other stocks do shareholders of Hologic own?: Based on aggregate information from My MarketBeat watchlists, some companies that other Hologic investors own include AbbVie (ABBV), NVIDIA (NVDA), Johnson & Johnson (JNJ), Alibaba Group (BABA), Walt Disney (DIS), PayPal (PYPL), Advanced Micro Devices (AMD), CVS Health (CVS), Pfizer (PFE) and Abbott Laboratories (ABT).
What is Hologic's stock symbol?: Hologic trades on the NASDAQ under the ticker symbol "HOLX."
How do I buy shares of Hologic?: Shares of HOLX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.
What is Hologic's stock price today?: One share of HOLX stock can currently be purchased for approximately $64.52.
How much money does Hologic make?: Hologic (NASDAQ:HOLX) has a market capitalization of $16.11 billion and generates $5.63 billion in revenue each year. The medical equipment provider earns $1.87 billion in net income (profit) each year or $5.93 on an earnings per share basis.
How many employees does Hologic have?: The company employs 6,705 workers across the globe.
Does Hologic have any subsidiaries?: The following companies are subsidiares of Hologic: Acessa Health, Acessa Health Inc., Beijing Hologic Technology Co. Ltd., Benassar Diagnostica-Equipamientos Medicos Unipessoal Lda., BioLucent, BioLucent LLC, Bioptics Inc., Biotheranostics Inc, Biotheranostics Inc., Bolder Surgical, Cynosure, Cytyc, Cytyc Corporation, Cytyc Prenatal Products Corp., Cytyc Surgical Products LLC, Diagenode Co. Ltd., Diagenode LLC, Diagenode SA, Diagenode SA., Diagenode SPA, Direct Radiography Corp., Emsor Sociedad de responsabilidad limitada, Faxitron Bioptics, Faxitron Bioptics LLC, Focal Therapeutics, Gen-Probe, Gen-Probe Incorporated, Gen-Probe Prodesse Inc., Gen-Probe Sales & Service Inc., Genewave SAS, Health Beacons Inc, Health Beacons Inc., Hologic (Australia & New Zealand) Pty Ltd., Hologic (MA) LLC, Hologic (Shanghai) Medical Supplies Co. Ltd., Hologic ASE LLC, Hologic Asia Limited, Hologic Asia Pacific Limited, Hologic Austria GmbH, Hologic BV, Hologic Bermuda Limited, Hologic Canada ULC, Hologic Caribbean (Barbados) SRL, Hologic Denmark ApS, Hologic Deutschland GmbH, Hologic Espana S.A., Hologic Finance Ltd., Hologic France SARL, Hologic GGO 2 LLC, Hologic GGO 3 LLP, Hologic GGO 4 LTD, Hologic Global Holding LTD, Hologic HUB LTD, Hologic Hitec-Imaging, Hologic Hitec-Imaging GmbH, Hologic Holdings Limited, Hologic IP LTD, Hologic Iberia S.L., Hologic India LLP, Hologic International Holdings B.V., Hologic Ireland Limited, Hologic Italia S.r.l., Hologic Japan KK, Hologic Latin America (Servicos Em Marketing E Negocios) Ltda., Hologic Ltd., Hologic Malaysia SDN. BHD., Hologic Medical Technologies (Beijing) Co. Ltd., Hologic Medicor GmbH, Hologic Medicor Suisse GmbH, Hologic Netherlands B.V., Hologic Nordic Holdings Oy, Hologic Singapore Pte. Ltd, Hologic Suisse SA, Hologic Surgical Products Costa Rica S.R.L., Hologic Sweden AB, Hologic Taiwan Ltd., Hologic UK Finance Ltd., Hologic US Finance Co LLC, Interlace Medical, Mobidiag Oy, Mobidiag Oy., Mobidiag UK Ltd., NXT-Dx SCRL, Navigation Three Limited, R2 Technology, Sentinelle Medical, Somatex (HK) Limited, Somatex Medical Technologies GmbH, Somatex Medical Technologies GmbH., Somatex USA Inc., SuperSonic Imagine (Shanghai) Medical Devices Co. Ltd., SuperSonic Imagine GmbH, SuperSonic Imagine HK Ltd, SuperSonic Imagine Ltd, SuperSonic Imagine SA, SuperSonic Imagine Srl, Suros Surgical Systems, Suros Surgical Systems Inc., TCT International, TCT International Co. Ltd., Third Wave Technologies, and Tridaho LLC.
Read More
How can I contact Hologic?: Hologic's mailing address is 250 CAMPUS DRIVE, MARLBOROUGH MA, 01752. The official website for the company is www.hologic.com. The medical equipment provider can be reached via phone at (508) 263-2900, via email at michael.watts@hologic.com, or via fax at 781-890-8031.

This page (NASDAQ:HOLX) was last updated on 10/1/2022 by MarketBeat.com Staff

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

Hologic - HOLX Stock Forecast, Price & News

Hologic MarketRank™ Forecast

Overall MarketRank™

Analyst's Opinion

Short Interest

Percentage of Shares Shorted

Short Interest Ratio / Days to Cover

Change versus previous month

Dividend Strength

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score

Environmental Sustainability

News and Social Media Coverage

News Sentiment

News Coverage This Week

Search Interest

MarketBeat Follows